Mirtazapine and Bupropion Combination Therapy for Depression
Mirtazapine can be safely and effectively administered with bupropion, offering complementary benefits for treating depression with potentially fewer side effects than either medication alone. 1
Rationale for Combination
The combination of mirtazapine and bupropion provides several therapeutic advantages:
Complementary mechanisms of action:
Enhanced efficacy: Combination therapy with mirtazapine and bupropion may double the likelihood of remission compared to monotherapy 1, 3
Counterbalancing side effects:
Dosing Recommendations
Mirtazapine:
Bupropion:
Clinical Benefits of This Combination
Improved remission rates:
- Studies show combination therapy may achieve remission rates of 46% compared to 25% with SSRI monotherapy 3
Reduced side effect burden:
Particularly useful for specific symptom profiles:
Potential Concerns and Management
Seizure risk with bupropion:
- Gradually titrate bupropion dose
- Avoid in patients with seizure disorders 2
Sedation with mirtazapine:
Weight considerations:
Restless legs syndrome:
- If RLS develops with mirtazapine, bupropion may actually help resolve this side effect 6
Monitoring Recommendations
- Assess response within 1-2 weeks (early improvements may be seen)
- Full therapeutic effect typically observed at 4-6 weeks 2
- Monitor for:
- Changes in sleep patterns
- Appetite and weight changes
- Sexual function
- Mood and energy levels
Clinical Pearl
The combination of mirtazapine and bupropion represents a rational pharmacological approach that targets multiple neurotransmitter systems (serotonin, norepinephrine, and dopamine) while potentially minimizing side effects that might occur with either agent alone 1, 5. This combination may be particularly valuable for patients who have not responded adequately to monotherapy or who experience troublesome side effects with single agents.